Indications and uses
For the support & balancing of the entire neurological system
For the support & balancing of the entire neurological system
Normal storage use. Do not use if tamper-evident seal is broken or removed.
5-Hydroxytryptophan 15X 200K, Acetylcholinesterase 15X 200K, Choline chloride 15X 200K, Dopamine 15X 200K, Glutamic acid 15X 200K, Glycine 15X 200K, Histidine 15X 200K, L-Dopa 15X 200K, Malvin 15X 200K, Melanin 15X 200K, Melatonin 15X 200K, Nitric oxide 15X 200K, Norepinephrine 15X 200K, Octopamine 15X 200K, O-Methyl serotonin 15X 200K, Phenylalanine 15X 200K, Serotonin 15X 200K, Taurine 15X 200K, Tryptophan 15X 200K, Tyrosine 15X 200K
| 5-Hydroxytryptophan | Stimulates serotonin |
| Acetylcholinesterase | Neuromuscular support |
| Choline chloride | Drainage |
| Dopamine | Neurological support |
| Glutamic acid | Neurological support |
| Glycine | Anti-aging |
| Histidine | Ig support |
| L-Dopa | Neurological support |
| Malvin | Neurological support |
| Melanin | Neurological support |
| Melatonin | Neurological support |
| Nitric oxide | Drainage |
| Norepinephrine | Neurological support |
| Octopamine | Drainage |
| O-Methyl serotonin | Drainage |
| Phenylalanine | Amino Acid Support |
| Serotonin | Neurological support |
| Taurine | Drainage |
| Tryptophan | Amino Acid Support |
| Tyrosine | Amino Acid Support |
For the support & balancing of the entire neurological system
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
20% Alcohol and 80% Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0463
NDC
63776-373-15
Homeopathic remedy
Neuro 3
• For the support & balancing of the entire neurological system
Oral spray
50ml 1.7 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Neuro 3
50 mL
1.7 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0463
NDC: 63776-373-15
INDICATIONS:
For the support & balancing of the entire neurological systems
DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-373-15 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-5f60-d83d-e063-dadaa90ab31f | Neuro 3 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-373-15 | Neuro 3 | 50 mL in 1 BOTTLE, SPRAY | SPRAY | 50 | 5 | |
| 63776-373-15 | Neuro 3 | 1 in 1 BOX | SPRAY | 1 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-373 | NEURO 3 (OXITRIPTAN, ACETYLCHOLINESTERASE HUMAN, CHOLINE CHLORIDE, DOPAMINE, GLUTAMIC ACID, GLYCINE, HISTIDINE, LEVODOPA, MALVIN, MELANIN SYNTHETIC (TYROSINE, PEROXIDE), NITRIC OXIDE, NOREPINEPHRINE, OCTOPAMINE, O-METHYL SEROTONIN, PHENYLALANINE, SEROTONIN, TAURINE, TRYPTOPHAN, TYROSINE) SPRAY [VIATREXX BIO INCORPORATED] | 5 | Legacy NDC, 2 package rows | 20230111_ca3c681c-5e5b-34d0-5917-549529afa65d.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| 5-methoxytryptamine | ACTIVE INGREDIENT | 3VMW6141KC | 1 | |
| Acetylcholinesterase Human | ACTIVE INGREDIENT | EK71H4HC3N | 1 | |
| Choline Chloride | ACTIVE INGREDIENT | 45I14D8O27 | 1 | |
| Dopamine | ACTIVE INGREDIENT | VTD58H1Z2X | 1 | |
| Glutamic Acid | ACTIVE INGREDIENT | 3KX376GY7L | 1 | |
| Glycine | ACTIVE INGREDIENT | TE7660XO1C | 1 | |
| Histidine | ACTIVE INGREDIENT | 4QD397987E | 1 | |
| Levodopa | ACTIVE INGREDIENT | 46627O600J | 1 | |
| Malvin | ACTIVE INGREDIENT | I9I120531L | 1 | |
| Melanin Synthetic (tyrosine, Peroxide) | ACTIVE INGREDIENT | O0CV1RMR44 | 1 | |
| Melatonin | ACTIVE INGREDIENT | JL5DK93RCL | 1 | |
| Nitric Oxide | ACTIVE INGREDIENT | 31C4KY9ESH | 1 | |
| Norepinephrine | ACTIVE INGREDIENT | X4W3ENH1CV | 1 | |
| Octopamine | ACTIVE INGREDIENT | 14O50WS8JD | 1 | |
| Oxitriptan | ACTIVE INGREDIENT | C1LJO185Q9 | 1 | |
| Phenylalanine | ACTIVE INGREDIENT | 47E5O17Y3R | 1 | |
| Serotonin | ACTIVE INGREDIENT | 333DO1RDJY | 1 | |
| Taurine | ACTIVE INGREDIENT | 1EQV5MLY3D | 1 | |
| Tryptophan | ACTIVE INGREDIENT | 8DUH1N11BX | 1 | |
| Tyrosine | ACTIVE INGREDIENT | 42HK56048U | 1 | |
| 5-methoxytryptamine | ACTIVE MOIETY | 3VMW6141KC | 1 | |
| Acetylcholinesterase Human | ACTIVE MOIETY | EK71H4HC3N | 1 | |
| Choline | ACTIVE MOIETY | N91BDP6H0X | 1 | |
| Dopamine | ACTIVE MOIETY | VTD58H1Z2X | 1 | |
| Glutamic Acid | ACTIVE MOIETY | 3KX376GY7L | 1 | |
| Glycine | ACTIVE MOIETY | TE7660XO1C | 1 | |
| Histidine | ACTIVE MOIETY | 4QD397987E | 1 | |
| Levodopa | ACTIVE MOIETY | 46627O600J | 1 | |
| Malvin | ACTIVE MOIETY | I9I120531L | 1 | |
| Melanin Synthetic (tyrosine, Peroxide) | ACTIVE MOIETY | O0CV1RMR44 | 1 | |
| Melatonin | ACTIVE MOIETY | JL5DK93RCL | 1 | |
| Nitric Oxide | ACTIVE MOIETY | 31C4KY9ESH | 1 | |
| Norepinephrine | ACTIVE MOIETY | X4W3ENH1CV | 1 | |
| Octopamine | ACTIVE MOIETY | 14O50WS8JD | 1 | |
| Oxitriptan | ACTIVE MOIETY | C1LJO185Q9 | 1 | |
| Phenylalanine | ACTIVE MOIETY | 47E5O17Y3R | 1 | |
| Serotonin | ACTIVE MOIETY | 333DO1RDJY | 1 | |
| Taurine | ACTIVE MOIETY | 1EQV5MLY3D | 1 | |
| Tryptophan | ACTIVE MOIETY | 8DUH1N11BX | 1 | |
| Tyrosine | ACTIVE MOIETY | 42HK56048U | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-373 | 63776-373-15 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| OXITRIPTAN | C1LJO185Q9 | ACTIB |
| ACETYLCHOLINESTERASE HUMAN | EK71H4HC3N | ACTIB |
| CHOLINE CHLORIDE | 45I14D8O27 | ACTIB |
| DOPAMINE | VTD58H1Z2X | ACTIB |
| GLUTAMIC ACID | 3KX376GY7L | ACTIB |
| GLYCINE | TE7660XO1C | ACTIB |
| HISTIDINE | 4QD397987E | ACTIB |
| LEVODOPA | 46627O600J | ACTIB |
| MALVIN | I9I120531L | ACTIB |
| MELANIN SYNTHETIC (TYROSINE, PEROXIDE) | O0CV1RMR44 | ACTIB |
| MELATONIN | JL5DK93RCL | ACTIB |
| NITRIC OXIDE | 31C4KY9ESH | ACTIB |
| NOREPINEPHRINE | X4W3ENH1CV | ACTIB |
| OCTOPAMINE | 14O50WS8JD | ACTIB |
| 5-METHOXYTRYPTAMINE | 3VMW6141KC | ACTIB |
| PHENYLALANINE | 47E5O17Y3R | ACTIB |
| SEROTONIN | 333DO1RDJY | ACTIB |
| TAURINE | 1EQV5MLY3D | ACTIB |
| TRYPTOPHAN | 8DUH1N11BX | ACTIB |
| TYROSINE | 42HK56048U | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f1ec339b-9183-999d-e053-2995a90ac45a | ca3c681c-5e5b-34d0-5917-549529afa65d | 2023-01-10 | Warnings | f1ec339b-9183-999d-e053-2995a90ac45a ca3c681c-5e5b-34d0-5917-549529afa65d |
Adverse event summaries are temporarily unavailable. Other product information remains available.